Author: Lombardi, A.M.
Paper Title Page
MOPAB413 The Next Ion Medical Machine Study at CERN: Towards a Next Generation Cancer Research and Therapy Facility with Ion Beams 1240
 
  • M. Vretenar, V. Bencini, E. Benedetto, M.R. Khalvati, A.M. Lombardi, M. Sapinski, D. Tommasini
    CERN, Geneva, Switzerland
  • E. Benedetto, M. Sapinski
    TERA, Novara, Italy
  • P. Foka
    GSI, Darmstadt, Germany
 
  Cancer therapy with ions has several advantages over X-ray and proton therapy, but its diffusion remains limited primarily because of the size and cost of the accelerator. To develop technologies that might improve performance and reduce accelerator cost with respect to present facilities, CERN has recently launched the Next Ion Medical Machine Study (NIMMS), leveraging CERN expertise in accelerator fields to disseminate technologies developed for basic science. A perspective user and key partner of NIMMS is the SEEIIST (South East European International Institute for Sustainable Technologies), established to build in the region an innovative facility for combined cancer therapy and biomedical research with ion beams. For SEEIIST and other potential users, three options are being considered. Conceptual designs of a warm-magnet synchrotron at high beam intensity, of a compact superconducting synchrotron, and of a high-frequency linear accelerator have been compared in terms of cost, risk and development time. The development of curved superconducting magnets, of compact synchrotrons and ion gantries, and of linacs is being pursued within EU-funded projects or specific collaborations  
DOI • reference for this paper ※ https://doi.org/10.18429/JACoW-IPAC2021-MOPAB413  
About • paper received ※ 18 May 2021       paper accepted ※ 20 July 2021       issue date ※ 13 August 2021  
Export • reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)